Cargando…

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer

Neuroendocrine prostate cancer (NEPC) is the most lethal malignancy of prostate cancer (PCa). Treatment with next-generation androgen receptor (AR) pathway inhibitors (ARPIs) has successfully extended patients' lifespan. However, with the emergence of drug resistance, PCa tumors increasingly ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Wen-Chi, Wang, Hung-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323647/ https://www.ncbi.nlm.nih.gov/pubmed/34386358 http://dx.doi.org/10.4103/tcmj.tcmj_220_20

Ejemplares similares

Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
por: Zhang, Shouyi, et al.
Publicado: (2023)

The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer
por: Singh, Prashant Kumar, et al.
Publicado: (2013)

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
por: Cejas, Paloma, et al.
Publicado: (2021)

Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
por: Jung, Inkyung, et al.
Publicado: (2023)

Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
por: Zamora, Irene, et al.
Publicado: (2023)

The genetics of neuroendocrine prostate cancers: a review of current and emerging candidates
por: Ather, M Hammad, et al.
Publicado: (2012)

Overcome cancer drug resistance by targeting epigenetic modifications of centrosome
por: Jia, Zan-Hui, et al.
Publicado: (2019)

Targeting Epigenetic Modifications in Uveal Melanoma
por: Chokhachi Baradaran, Pooneh, et al.
Publicado: (2020)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases
por: Teng, Pai-Chi, et al.
Publicado: (2021)

Targeting Protein Kinases and Epigenetic Control as Combinatorial Therapy Options for Advanced Prostate Cancer Treatment
por: Bagheri, Soghra, et al.
Publicado: (2022)

Epigenetic modifications of histones in cancer
por: Zhao, Zibo, et al.
Publicado: (2019)

Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer
por: Xu, Xiang, et al.
Publicado: (2017)

Narrative review of challenges in the management of advanced neuroendocrine prostate cancer
por: Okasho, Kosuke, et al.
Publicado: (2021)

Epigenetic modification mechanisms involved in keloid: current status and prospect
por: Lv, Wenchang, et al.
Publicado: (2020)

Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
por: Chen, Chia-Lin, et al.
Publicado: (2021)

The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
por: Storck, William K., et al.
Publicado: (2022)

Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies
por: Zhu, Li-Ran, et al.
Publicado: (2021)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Mafficini, Andrea, et al.
Publicado: (2019)

Epigenetic modifications and diabetic nephropathy
por: Reddy, Marpadga A., et al.
Publicado: (2012)

Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
por: Shu, Feng, et al.
Publicado: (2023)

Epigenetic Modifications as Therapeutic Targets
por: Kelly, Theresa K, et al.
Publicado: (2010)

Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Epigenetic Modifications in Head and Neck Cancer
por: Gaździcka, Jadwiga, et al.
Publicado: (2019)

Gastroenteropancreatic Neuroendocrine Tumors—Current Status and Advances in Diagnostic Imaging
por: Vogele, Daniel, et al.
Publicado: (2023)

Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
por: Zhu, Xuguang, et al.
Publicado: (2017)

Connections between metabolism and epigenetic modifications in cancer
por: Wang, Guangchao, et al.
Publicado: (2022)

Epigenetics in Prostate Cancer
por: Albany, Costantine, et al.
Publicado: (2011)

The role of epigenetic modifications in Colorectal Cancer Metastasis
por: Su, Riya, et al.
Publicado: (2022)

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy
por: Naseer, Faiza, et al.
Publicado: (2019)

Epigenetic regulation of prostate cancer
por: Wang, Ruixin, et al.
Publicado: (2019)

Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
por: Lu, Heng-Cheng, et al.
Publicado: (2021)

Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Alexandraki, Krystallenia I., et al.
Publicado: (2017)

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
por: Cheng, Yuan, et al.
Publicado: (2019)

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Epigenetic regulation of prostate cancer
por: Chin, Suyin P., et al.
Publicado: (2011)

Metabolic reprogramming and epigenetic modifications on the path to cancer
por: Sun, Linchong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_24db7e6hac63lfkl7ltmquc9eh